Q2 2023 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q2 and H1 FY '23 Earnings Conference Call of Eris Lifesciences Limited.
We have with us on the call today, Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.
Thank you. Good afternoon, and welcome to our earnings call for the second quarter of financial year '23. I'm Krishnakumar, and I'll be sharing the highlights of this quarter and the first half of the year over you.
Oaknet, our recent acquisition in the month of May 2002 is emerging as a clear success story in value creation through M&A. Oaknet's growth momentum continues with quarter 2 revenue of INR 68 crores and EBITDA of INR 16.5 crores, which
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
